More Headlines

DrugSense

DURECT Reports Data From European Phase IIb Hysterectomy Study of Posidur (SABER-Bupivacaine)

CUPERTINO, Calif., June 16 /PRNewswire-FirstCall/ — DURECT
Corporation (Nasdaq: DRRX) announced today results from a European
Phase IIb hysterectomy clinical trial conducted by Nycomed of
POSIDUR™ (also known as SABER™-bupivacaine…

Abbott Vascular Lays Off Workers

Abbott Vascular Lays Off Workers [The Press-Enterprise,
Riverside, Calif.]

From Press-Enterprise (Riverside, CA) (June 17, 2010)

Jun. 17–Abbott Vascular, Temecula’s largest private employer
and a division of Abbott Laboratories, has laid…

Hospira Announces Further Extension of Tender Offer for Shares of Javelin Pharmaceuticals

LAKE FOREST, Ill., June 17 /PRNewswire-FirstCall/ — Hospira,
Inc. (NYSE:
HSP) , a global specialty pharmaceutical and medication
delivery company, today announced a further extension of the tender
offer by Discus Acquisition Corporation, a wholly…

Bayer Schering Pharma and OncoMed Pharmaceuticals Enter Strategic Alliance to Develop Anti-Cancer Stem Cell Therapeutics

- Collaboration Focuses on the Discovery and Development of
Multiple Antibody, Protein and Small Molecule Agents Targeting the
Wnt Pathway
Berlin/Redwood City, June 17, 2010 – Bayer Schering Pharma AG,
Germany, and OncoMed Pharmaceuticals, Inc.,…

Merck KGaA Resumes Stimuvax Clinical Program in Lung Cancer

Darmstadt, Germany, June 17 2010 –Merck KGaA and its U.S.
affiliate, EMD Serono, Inc. today announced that they are resuming
their Stimuvax® (BLP25 liposome vaccine*) clinical program in
patients with non-small cell lung cancer (NSCLC),…